文献速递主动脉疾病内脏/肾动脉与血管畸形

远端自膨式联合近端球扩式支架桥接困难肾动脉在胸腹主动脉分支腔内修复中的应用

The Combined Use of a Distal Self-Expandable and Proximal Balloon-Expandable Stent Graft in Bridging Hostile Renal Arteries in Thoracoabdominal Branched Endografting.
PubMed 文献 · Ann Vasc Surg · 2020-04-23

本研究回顾性分析2010-2019年112例胸腹主动脉瘤行开窗/分支腔内修复术的患者,评估在困难肾动脉解剖(B/D型)中采用远端自膨式(SE)联合近端球扩式(BE)支架桥接的早中期结果,并与单纯BE支架比较。结果显示联合组在24个月随访中肾动脉通畅率更高、再干预率和分支不稳发生率更低。

要点

  • 在困难肾动脉解剖中,SE+BE桥接支架较单纯BE支架降低肾动脉闭塞率(2.5% vs 27%,P=0.017)。
  • SE+BE组12个月通畅率90±5% vs BE组68±5%(P=0.039),再干预率更低(P=0.01)。
  • SE+BE组分支不稳发生率更低(7.5% vs 33.3%,P=0.02),中期随访安全有效。

核心结论

  • 在困难肾动脉解剖中,分支腔内修复采用远端SE联合近端BE支架桥接安全有效,中期随访闭塞、再干预和分支不稳率均低于单纯BE支架。

研究设计与样本

  • 回顾性分析2010-2019年前瞻性收集的112例胸腹主动脉瘤行开窗/分支腔内修复术患者的肾动脉数据。
  • 共189条肾动脉接受开窗(113条,60%)或分支(76条,40%)治疗,其中66条(86%)由分支设计并完成造影通畅,55条为B/D型困难解剖。
  • 55条困难肾动脉中,15条(27%)使用单纯BE支架,40条(73%)使用SE+BE联合支架。

主要发现

  • 中位随访12(8)个月,55条肾动脉中5条(9%)闭塞:BE组4/15(27%),SE+BE组1/40(2.5%)(P=0.017)。
  • 24个月肾动脉总通畅率为83±5%;SE+BE组12个月通畅率90±5%,高于BE组的68±5%(P=0.039)。
  • 24个月免于肾动脉相关再干预率为87±5%;SE+BE组12个月免于再干预率93±5%,高于BE组的76±5%(P=0.01)。
  • 24个月免于分支不稳率为78±5%;SE+BE组12个月免于分支不稳率80±5%,高于BE组的68±5%(P=0.02)。

临床怎么用

  • 对于胸腹主动脉瘤分支腔内修复中遇B/D型困难肾动脉解剖,可优先考虑远端SE联合近端BE支架桥接以改善中期通畅性。

局限性

  • 本研究为单中心回顾性分析,样本量有限,随访时间较短,结论需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate early/midterm outcomes of a specific configuration of a bridging stent graft-that is a distal self-expandable (SE) stent graft combined with proximal balloon-expandable (BE) one-in hostile renal artery (RA) anatomy in branched thoracoabdominal aneurysm (TAAA) repair. METHODS: Between 2010 and 2019, all TAAAs undergoing fenestrated and branched endografting (FB-EVAR) were prospectively collected. Preoperative, procedural, and postoperative data of RAs accommodated by branch design and patent at the completion angiography were retrospectively analyzed. Hostile RA anatomy included upward (type B) and downward + upward (type D) orientations. Type B and D RAs treated by the combination of an SE + BE stent graft as a bridging stent (BE + SE group) were compared with RAs treated by a BE stent graft only (BE group). RA occlusion, reinterventions, and branch instability were assessed. RESULTS: Over a total of 112 TAAAs undergoing FB-EVAR, 189 RAs were treated by fenestrations (113-60%) and branches (76-40%). Among the 66 (86%) RAs accommodated by branch and patent at completion angiography, 55 had a type B/D orientation. BE stent grafts were used in 15/55 (27%) RAs and SE + BE in 40/55 (73%). At a median follow-up of 12 (8) months, 5/55 (9%) RAs occluded: 4/15 (27%) in the BE group and 1/40(2.5%) in the SE + BE group (P: 0.017). RA patency was 83 ± 5% at 24 months. The SE + BE group had higher patency than the BE group (90 ± 5% vs. 68 ± 5% at 12 months; P: 0.039). Overall freedom from RA-related reinterventions was 87 ± 5% at 24 months. Six (9%) RAs required reinterventions: 4/15 (27%) in the BE group and 2/40 (5%) in the BE + SE group (P: 0.041). RAs managed by an SE + BE stent graft had lower reinterventions than RAs treated by a BE stent graft only (93 ± 5% vs. 76 ± 5% at 12 months; P: 0.01). Freedom from branch instability was 78 ± 5% at 24 months, with 8 overall cases (12%) occurring-5/15 (33.3%) in the BE group versus 3/40 (7.5%) in the SE + BE group (P: 0.02). RAs managed by an SE + BE stent graft had lower branch instability than RAs treated only by a BE stent graft (BE: 68 ± 5% vs. SE + BE: 80 ± 5% at 12 months; P: 0.02). CONCLUSIONS: In hostile renal anatomy, the combination of a distal SE and proximal BE stent graft as a bridging stent in branched endografting is safe and effective with lower rates of occlusion, reinterventions, and branch instability at midterm follow-up compared with a BE stent graft alone.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Faggioli G, Fenelli C, et al. The Combined Use of a Distal Self-Expandable and Proximal Balloon-Expandable Stent Graft in Bridging Hostile Renal Arteries in Thoracoabdominal Branched Endografting. Ann Vasc Surg. 2020. PMID: 32335256. doi:10.1016/j.avsg.2020.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。